Abstract
Cancer cells undergo accelerated evolutionary changes; thus, under the pressure of novel generations of EGFR TKIs, we should expect to see new mechanisms of resistance.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 616-618 |
| Number of pages | 3 |
| Journal | Oncology (United States) |
| Volume | 30 |
| Issue number | 7 |
| State | Published - Jul 15 2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Management of resistance to EGFR TKI–Targeted therapy of lung cancer: Lessons in monitoring cancer evolution'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS